US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 2.360
  • -0.020-0.84%
Trading Feb 26 15:16 ET
173.78MMarket Cap-15.73P/E (TTM)

About Protalix Biotherapeutics Company

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Company Profile

SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees208
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Websitehttp://www.protalix.com

Company Executives

  • Name
  • Position
  • Salary
  • Dror Bashan
  • Director, President and Chief Executive Officer
  • 2.68M
  • Eyal Rubin
  • Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
  • 1.03M
  • Yaron Naos
  • Senior Vice President, Operations
  • 776.37K
  • Dr. Eliot Richard Forster, M.B.A.,PhD
  • Chairman of the Board
  • 47.99K
  • Gwen A. Melincoff
  • Independent Director
  • 79.91K
  • Dr. Aharon Schwartz,PhD
  • Independent Director
  • 79.91K
  • Amos Bar Shalev
  • Independent Director
  • 79.91K
  • Dr. Shmuel Ben-Zvi, PhD
  • Independent Director
  • 74.71K
  • Dr. Pol F. Boudes,M.D.
  • Independent Director
  • 115.39K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
CG MED EQUIP.
838810
+29.94%
SUZHOUBEARING
430418
+22.35%
4
COCYBER
835207
+21.31%
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
+20.05%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.